Recent Developments in Proteolysis Targeting Chimeras
In this Q&A, Craig Crews, PhD, discusses the discovery and development of proteolysis targeting chimeras, a new modality that is being explored for both drug discovery and therapeutic application
Richie Kohman, PhD, discusses in situ RNA sequencing and its emerging applications
Daniel E. Austin and Christopher C. Mulligan discuss the latest developments in portable mass spectrometers